LEMAITRE VASCULAR INC's ticker is LMAT and the CUSIP is 525558201. A total of 182 filers reported holding LEMAITRE VASCULAR INC in Q4 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $2,781,323 | +120.7% | 41,913 | +88.7% | 0.02% | +100.0% |
Q4 2023 | $1,260,469 | -62.3% | 22,207 | -63.8% | 0.01% | -68.0% |
Q3 2023 | $3,344,854 | +1597.4% | 61,396 | +1503.4% | 0.02% | +2400.0% |
Q1 2023 | $197,063 | -40.3% | 3,829 | -41.1% | 0.00% | -50.0% |
Q3 2022 | $330,000 | -73.0% | 6,502 | -75.3% | 0.00% | -80.0% |
Q1 2022 | $1,221,000 | +4.9% | 26,280 | +13.4% | 0.01% | -9.1% |
Q4 2021 | $1,164,000 | +8.2% | 23,165 | +14.3% | 0.01% | -21.4% |
Q3 2021 | $1,076,000 | +19.0% | 20,262 | +36.8% | 0.01% | +40.0% |
Q2 2021 | $904,000 | -37.7% | 14,813 | -50.2% | 0.01% | -47.4% |
Q1 2021 | $1,450,000 | -12.3% | 29,724 | -27.2% | 0.02% | -17.4% |
Q4 2020 | $1,654,000 | +270.9% | 40,844 | +156.0% | 0.02% | +187.5% |
Q2 2019 | $446,000 | +112.4% | 15,957 | +135.5% | 0.01% | +14.3% |
Q1 2019 | $210,000 | -10.6% | 6,776 | +7.8% | 0.01% | -46.2% |
Q3 2017 | $235,000 | – | 6,287 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWM Investment Company, Inc. | 350,194 | $11,724,000 | 1.96% |
Ranger Investment Management | 699,843 | $23,431,000 | 1.64% |
THB ASSET MANAGEMENT | 392,100 | $13,127,000 | 1.60% |
PERKINS CAPITAL MANAGEMENT INC | 64,550 | $2,161,000 | 1.55% |
Conestoga Capital Advisors, LLC | 1,392,591 | $46,624,000 | 1.50% |
Summit Creek Advisors LLC | 213,761 | $7,157,000 | 1.28% |
Biondo Investment Advisors, LLC | 107,405 | $3,603,000 | 0.91% |
Concorde Asset Management, LLC | 21,207 | $710,000 | 0.81% |
Capital Impact Advisors, LLC | 51,542 | $1,739,000 | 0.64% |
Sapphire Star Partners LP | 12,290 | $412,000 | 0.42% |